Table 4.

Investigator-assessed best overall responses

	Q3W dosing					Q1W dosing		All patients (N = 39)
	0.3 mg/kg (n = 3)	0.6 mg/kg (n = 3)	1.2 mg/kg (n = 3)	1.8 mg/kg (n = 7)	2.4 mg/kg (n = 17)	0.8 mg/kg (n = 3)	1.1 mg/kg (n = 3)
Partial response	0	0	0	0	2 (12%)	0	0	2 (5%)
Minimal response	0	1 (33%)	0	0	0	0	0	1 (3%)
Stable disease	0	1 (33%)	1 (33%)	4 (57%)	9 (53%)	1 (33%)	2 (67%)	18 (46%)
Progressive disease	3 (100%)	1 (33%)	2 (67%)	3 (43%)	5 (29%)	2 (67%)	0	16 (41%)